Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wendi Li

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Annals of Medicine|June 19, 2026
Targeted activation of PPARG or AKT1 alleviates liver injury in mice with type 2 diabetes and sepsis by modulating inflammatory and metabolic pathwaysJie Ma, Xin Qi, Wendi Li, et al.
Nature Biotechnology|July 22, 2008
A small molecule enhances RNA interference and promotes microRNA processingGe Shan, Yujing Li, Junliang Zhang, et al.
Mabs|June 14, 2023
A HER2-targeted antibody-novel DNA topoisomerase I inhibitor conjugate induces durable adaptive antitumor immunity by activating dendritic cellsXiaoding Tan, Peng Fang, Kaiying Li, et al.
Plos Genetics|July 26, 2012
Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathwayCourtney A Lovejoy, Wendi Li, Steven Reisenweber, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Annals of Medicine|June 19, 2026
Targeted activation of PPARG or AKT1 alleviates liver injury in mice with type 2 diabetes and sepsis by modulating inflammatory and metabolic pathwaysJie Ma, Xin Qi, Wendi Li, et al.
Nature Biotechnology|July 22, 2008
A small molecule enhances RNA interference and promotes microRNA processingGe Shan, Yujing Li, Junliang Zhang, et al.
Mabs|June 14, 2023
A HER2-targeted antibody-novel DNA topoisomerase I inhibitor conjugate induces durable adaptive antitumor immunity by activating dendritic cellsXiaoding Tan, Peng Fang, Kaiying Li, et al.
Plos Genetics|July 26, 2012
Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathwayCourtney A Lovejoy, Wendi Li, Steven Reisenweber, et al.
Pageof 7